Skip to main content

Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.

Publication ,  Journal Article
Bhalla, IP; Stefanovics, EA; Rosenheck, RA
Published in: Med Care
September 2017

OBJECTIVE: While research on substance abuse has largely focused on people who have a single substance use disorder (SUD), many people abuse multiple substances. Studies have yet to examine the distinctive characteristics of patients diagnosed with more than 1 SUD and how those with polysubstance use disorder (PSUD) differ from those with a single SUD. METHODS: National Veterans Health Administration data from fiscal year 2012 were used to compare veterans diagnosed 1 SUD to veterans diagnosed with 2-3, and >3 SUDs on demographic characteristics, psychiatric and medical diagnoses, medical and psychiatric service utilization, and psychotropic medication fills. Comparisons of the 3 groups were based on bivariate and multiple logistic regression analyses. RESULTS: Of the 472,624 veterans with at least 1 diagnosed SUD, 346,329 (73.2%) had 1 disorder, 113,598 (24.0%) had 2-3, and 12,715 (2.7%) had >3 SUDs. Veterans with higher levels of PSUD were more likely to be black and homeless, were more likely to have hepatic disease as well as schizophrenia, bipolar disorder, major depressive disorder, and personality disorders. Higher levels of PSUD were associated with greater use of psychiatric inpatient care, residential and rehabilitative treatment, and with multiple psychotropic medication prescription fills. CONCLUSIONS: Veterans with PSUD have more severe problems along several dimensions and use more numerous and varied services than those with 1 SUD. This distinctive clinical profile warrants research to develop and evaluate methods for treating patients with complex multimorbid disorders that involve interactions between medical morbidity and psychosocial dysfunction.

Duke Scholars

Published In

Med Care

DOI

EISSN

1537-1948

Publication Date

September 2017

Volume

55 Suppl 9 Suppl 2

Start / End Page

S24 / S32

Location

United States

Related Subject Headings

  • Veterans Health
  • United States Department of Veterans Affairs
  • United States
  • Substance-Related Disorders
  • Polypharmacy
  • Mental Health Services
  • Humans
  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bhalla, I. P., Stefanovics, E. A., & Rosenheck, R. A. (2017). Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care, 55 Suppl 9 Suppl 2, S24–S32. https://doi.org/10.1097/MLR.0000000000000731
Bhalla, Ish P., Elina A. Stefanovics, and Robert A. Rosenheck. “Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.Med Care 55 Suppl 9 Suppl 2 (September 2017): S24–32. https://doi.org/10.1097/MLR.0000000000000731.
Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care. 2017 Sep;55 Suppl 9 Suppl 2:S24–32.
Bhalla, Ish P., et al. “Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.Med Care, vol. 55 Suppl 9 Suppl 2, Sept. 2017, pp. S24–32. Pubmed, doi:10.1097/MLR.0000000000000731.
Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care. 2017 Sep;55 Suppl 9 Suppl 2:S24–S32.

Published In

Med Care

DOI

EISSN

1537-1948

Publication Date

September 2017

Volume

55 Suppl 9 Suppl 2

Start / End Page

S24 / S32

Location

United States

Related Subject Headings

  • Veterans Health
  • United States Department of Veterans Affairs
  • United States
  • Substance-Related Disorders
  • Polypharmacy
  • Mental Health Services
  • Humans
  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems